DeepMed Research

UNIVERSITY OF MISSOURI-COLUMBIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Metacognitive Strategy Training in Cancer-related Cognitive Impairment

Not Applicable

Completed

Conditions: Breast Cancer Female

Interventions: Behavioral: CO-OP Procedures
Behavioral: Attention Control Procedures

First Posted Date: 2022-08-17

Last Posted Date: 2024-12-16

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 46

Registration Number: NCT05505045

Locations: 🇺🇸
University of Missouri Occupational Therapy Department, Columbia, Missouri, United States

Leucine, MTOR and Athero

Not Applicable

Active, not recruiting

Conditions: Atherosclerosis

Interventions: Other: Meal

First Posted Date: 2022-07-22

Last Posted Date: 2025-03-17

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 10

Registration Number: NCT05470218

Locations: 🇺🇸
Washington University School of Medicine, St. Louis, Missouri, United States

PAL to Improve Oral Feeding for Infants With Chronic Lung Disease

Not Applicable

Recruiting

Conditions: Chronic Lung Disease of Prematurity
Preterm Birth
Bronchopulmonary Dysplasia
Respiratory Distress Syndrome in Premature Infant

Interventions: Device: Pacifier Activated Lullaby ®

First Posted Date: 2022-07-06

Last Posted Date: 2024-10-07

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 60

Registration Number: NCT05446389

Locations: 🇺🇸
University of Missouri Healthcare, Columbia, Missouri, United States

Exploring the Experiences and Outcomes of a Summer Intensive Therapy Program- Mixed Methods Study

Not Applicable

Completed

Conditions: Children With Neurodevelopmental Disorders

First Posted Date: 2022-07-05

Last Posted Date: 2023-03-24

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 15

Registration Number: NCT05443763

Locations: 🇺🇸
Children's Therapy Center--MU Healthcare, Columbia, Missouri, United States

Randomized Controlled Trial Comparing Irrisept Versus Normal Saline for Wound Irrigation After Posterior Spine Surgery

Phase 4

Withdrawn

Conditions: Cervical Spine Degeneration
Lumbar Spine Degeneration

Interventions: Drug: saline 0.9%
Drug: (0.05% chlorhexidine gluconate (CHG) in sterile water)

First Posted Date: 2022-06-07

Last Posted Date: 2022-12-27

Lead Sponsor: University of Missouri-Columbia

Registration Number: NCT05408923

Locations: 🇺🇸
Missouri Orthopaedic Institute, Columbia, Missouri, United States

Skin Preparation for Elective Foot and Ankle Surgery

Phase 4

Recruiting

Conditions: Microbial Colonization
Foot and Ankle Disorders

Interventions: Drug: Hibiclens
Drug: Isopropyl Alcohol 70% Topical Application Solution

First Posted Date: 2022-06-02

Last Posted Date: 2025-04-25

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 100

Registration Number: NCT05401292

Locations: 🇺🇸
University of Missouri, Columbia, Missouri, United States

Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF)

Not Applicable

Recruiting

Conditions: Cystic Fibrosis
Mucociliary Clearance Defect

Interventions: Other: Symptom driven performance of airway clearance
Other: Continuous daily performance of airway clearance

First Posted Date: 2022-05-26

Last Posted Date: 2023-09-07

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 30

Registration Number: NCT05392855

Locations: 🇺🇸
University of Missouri Hospital and Clinics, Columbia, Missouri, United States

Theta-burst Repetitive Transcranial Magnetic Stimulation (TBS) of the Right Inferior Frontal Gyrus for Treatment of Nicotine Dependence

Not Applicable

Not yet recruiting

Conditions: Tobacco Use Disorder

Interventions: Device: Sham Continuous Theta-burst stimulation (cTBS)
Device: Continuous Theta-burst stimulation (cTBS)

First Posted Date: 2022-05-25

Last Posted Date: 2024-08-14

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 60

Registration Number: NCT05389670

Short Term Sirolimus Treatment and MRI of the Brain and Lungs

Phase 1

Recruiting

Conditions: Genetic Predisposition to Disease
Healthy Volunteers

Interventions: Drug: Sirolimus

First Posted Date: 2022-05-23

Last Posted Date: 2025-03-30

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 205

Registration Number: NCT05386914

Locations: 🇺🇸
University of Missouri-Columbia, Columbia, Missouri, United States

Reducing COVID-19 Related Disability in Rural Community-Dwelling Older Adults Using Smart Technology

Not Applicable

Completed

Conditions: Quality of Life
Disabilities Multiple

Interventions: Behavioral: Self Management
Behavioral: Standard Health Education

First Posted Date: 2022-05-18

Last Posted Date: 2025-05-14

Lead Sponsor: University of Missouri-Columbia

Target Recruit Count: 58

Registration Number: NCT05379504

Locations: 🇺🇸
University of Missouri, Columbia, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy